Literature DB >> 100243

[Cartilaginous tissue and nalidixic acid].

H Bouissou, D Caujolle, F Caujolle, G Milhaud.   

Abstract

1. Medication with nalidixic acid never produced articular lesions in adult animals. 2. In the species of immature animals, if sensitive to nalidixic acid, the articular lesions were macroscopically and microscopically identical. 3. The lesions regressed spontaneously as the basal germinative layer was never affected.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100243

Source DB:  PubMed          Journal:  C R Acad Hebd Seances Acad Sci D


  6 in total

1.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

2.  Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C]Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection.

Authors:  A C Crémieux; A S Mghir; R Bleton; M Manteau; N Belmatoug; L Massias; L Garry; N Sales; B Mazière; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity.

Authors:  U B Schaad; J Wedgwood-Krucko
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

4.  Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo.

Authors:  M Kato; S Takada; S Ogawara; S Takayama
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

5.  Penetration of ofloxacin into nasal tissues.

Authors:  P Tolsdorff
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

6.  Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children.

Authors:  H Peltola; M Väärälä; O V Renkonen; P J Neuvonen
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.